The assessment of first-line anti-tuberculosis drug exposure, inflammatory biomarkers and pulmonary tuberculosis severity association with treatment response

V. Igumnova; A. Kivrane; A. Viksna; L. Pahirko; I. Ozere; I. Bogdanova; A. Krams; A. Cirule; S. Grinberga; E. Sevostjanovs; D. Bandere; R. Ranka

doi:10.1002/2211-5463.13440

The assessment of first-line anti-tuberculosis drug exposure, inflammatory biomarkers and pulmonary tuberculosis severity association with treatment response

V. Igumnova
, A. Kivrane
, A. Viksna
, L. Pahirko
, I. Ozere
, I. Bogdanova
, A. Krams
, A. Cirule
, S. Grinberga
, E. Sevostjanovs
, D. Bandere
, R. Ranka

Rīga Stradiņš University

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	318-319
Number of pages	2
Journal	FEBS Open Bio
Volume	12
Issue number	S1
DOIs	https://doi.org/10.1002/2211-5463.13440
Publication status	Published - Jul 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Field of Science

1.6 Biological sciences
3.2 Clinical medicine

Publication Type*

3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Access to Document

10.1002/2211-5463.13440

https://febs.onlinelibrary.wiley.com/doi/epdf/10.1002/2211-5463.13440

Cite this

Igumnova, V., Kivrane, A., Viksna, A., Pahirko, L., Ozere, I., Bogdanova, I., Krams, A., Cirule, A., Grinberga, S., Sevostjanovs, E., Bandere, D., & Ranka, R. (2022). The assessment of first-line anti-tuberculosis drug exposure, inflammatory biomarkers and pulmonary tuberculosis severity association with treatment response. FEBS Open Bio, 12(S1), 318-319. https://doi.org/10.1002/2211-5463.13440

@article{8b849ec4cfae4aa584da6bc7b14b3141,

title = "The assessment of first-line anti-tuberculosis drug exposure, inflammatory biomarkers and pulmonary tuberculosis severity association with treatment response",

author = "V. Igumnova and A. Kivrane and A. Viksna and L. Pahirko and I. Ozere and I. Bogdanova and A. Krams and A. Cirule and S. Grinberga and E. Sevostjanovs and D. Bandere and R. Ranka",

year = "2022",

month = jul,

doi = "10.1002/2211-5463.13440",

language = "English",

volume = "12",

pages = "318--319",

journal = "FEBS Open Bio",

issn = "2211-5463",

publisher = "John Wiley and Sons Inc.",

number = "S1",

}

Igumnova, V, Kivrane, A , Viksna, A, Pahirko, L, Ozere, I, Bogdanova, I, Krams, A, Cirule, A, Grinberga, S, Sevostjanovs, E, Bandere, D & Ranka, R 2022, 'The assessment of first-line anti-tuberculosis drug exposure, inflammatory biomarkers and pulmonary tuberculosis severity association with treatment response', FEBS Open Bio, vol. 12, no. S1, pp. 318-319. https://doi.org/10.1002/2211-5463.13440

TY - JOUR

T1 - The assessment of first-line anti-tuberculosis drug exposure, inflammatory biomarkers and pulmonary tuberculosis severity association with treatment response

AU - Igumnova, V.

AU - Kivrane, A.

AU - Viksna, A.

AU - Pahirko, L.

AU - Ozere, I.

AU - Bogdanova, I.

AU - Krams, A.

AU - Cirule, A.

AU - Grinberga, S.

AU - Sevostjanovs, E.

AU - Bandere, D.

AU - Ranka, R.

PY - 2022/7

Y1 - 2022/7

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=rsu_pure_&SrcAuth=WosAPI&KeyUT=WOS:000821444603184&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1002/2211-5463.13440

DO - 10.1002/2211-5463.13440

M3 - Meeting Abstract

SN - 2211-5463

VL - 12

SP - 318

EP - 319

JO - FEBS Open Bio

JF - FEBS Open Bio

IS - S1

ER -

The assessment of first-line anti-tuberculosis drug exposure, inflammatory biomarkers and pulmonary tuberculosis severity association with treatment response

UN SDGs

Field of Science

Publication Type*

Access to Document

Other files and links

Cite this